Feiteng Lu
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
-
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Fan Luo (13 shared papers)Hongyun Zhao (12 shared papers)Yan Huang (11 shared papers)Jiaxin Cao (9 shared papers)Wenjuan Ma (8 shared papers)Jianhua Zhan (6 shared papers)Ting Zhou (7 shared papers)Zhang Li (1 shared paper)
- Journals
- Cell Death and Disease (2 papers)Parasitology (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Food Science & Nutrition (1 paper)European Journal of Cancer Prevention (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Feiteng Lu
21 papers receiving 336 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 67
- Oncology 83
- Immunology 58
- Ophthalmology 21
- Oral Surgery 12
Countries citing papers authored by Feiteng Lu
This map shows the geographic impact of Feiteng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiteng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiteng Lu more than expected).
Fields of papers citing papers by Feiteng Lu
This network shows the impact of papers produced by Feiteng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiteng Lu. The network helps show where Feiteng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feiteng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 66 | |
| 2 | 2023 | 42 | |
| 3 | 2005 | 41 | |
| 4 | 2018 | 27 | |
| 5 | 2018 | 26 | |
| 6 | 2021 | 22 | |
| 7 | 2023 | 21 | |
| 8 | 2021 | 15 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2021 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2017 | 9 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2022 | 2 |
About Feiteng Lu
Feiteng Lu is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 22 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Mechanisms and Therapy (2 papers), Lung Cancer Treatments and Mutations (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Ubiquitin and proteasome pathways (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (67 citations), Oncology (83 citations), Immunology (58 citations), Ophthalmology (21 citations) and Oral Surgery (12 citations). Feiteng Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Fan Luo, Hongyun Zhao, Yan Huang, Jiaxin Cao, Wenjuan Ma, Jianhua Zhan, Ting Zhou, Zhang Li, Ling Yang and Donald Maxwell Parkin. Their work appears in journals such as Cell Death and Disease, Parasitology, Therapeutic Advances in Medical Oncology, Food Science & Nutrition and European Journal of Cancer Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.